127 related articles for article (PubMed ID: 15382041)
1. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice.
Iavnilovitch E; Cardiff RD; Groner B; Barash I
Int J Cancer; 2004 Nov; 112(4):607-19. PubMed ID: 15382041
[TBL] [Abstract][Full Text] [Related]
2. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
3. Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involution.
Iavnilovitch E; Eilon T; Groner B; Barash I
Mol Reprod Dev; 2006 Jul; 73(7):841-9. PubMed ID: 16596634
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
5. Forced activation of Stat5 subjects mammary epithelial cells to DNA damage and preferential induction of the cellular response mechanism during proliferation.
Eilon T; Barash I
J Cell Physiol; 2011 Mar; 226(3):616-26. PubMed ID: 20717961
[TBL] [Abstract][Full Text] [Related]
6. Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.
Eilon T; Barash I
BMC Genomics; 2009 May; 10():231. PubMed ID: 19450255
[TBL] [Abstract][Full Text] [Related]
7. The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3.
Chapman RS; Lourenco P; Tonner E; Flint D; Selbert S; Takeda K; Akira S; Clarke AR; Watson CJ
Adv Exp Med Biol; 2000; 480():129-38. PubMed ID: 10959419
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mammary gland factor/Stat5a during mammary gland development.
Kazansky AV; Raught B; Lindsey SM; Wang YF; Rosen JM
Mol Endocrinol; 1995 Nov; 9(11):1598-609. PubMed ID: 8584036
[TBL] [Abstract][Full Text] [Related]
9. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
Eilon T; Barash I
BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
[TBL] [Abstract][Full Text] [Related]
10. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
Liu X; Robinson GW; Hennighausen L
Mol Endocrinol; 1996 Dec; 10(12):1496-506. PubMed ID: 8961260
[TBL] [Abstract][Full Text] [Related]
11. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
[TBL] [Abstract][Full Text] [Related]
12. Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females.
Eilon T; Groner B; Barash I
Int J Cancer; 2007 Nov; 121(9):1892-1902. PubMed ID: 17640063
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.
Cui Y; Riedlinger G; Miyoshi K; Tang W; Li C; Deng CX; Robinson GW; Hennighausen L
Mol Cell Biol; 2004 Sep; 24(18):8037-47. PubMed ID: 15340066
[TBL] [Abstract][Full Text] [Related]
14. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation.
Saunier E; Dif F; Kelly PA; Edery M
Endocrinology; 2003 Jun; 144(6):2669-75. PubMed ID: 12746331
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
Mitchell TJ; Whittaker SJ; John S
Cancer Res; 2003 Dec; 63(24):9048-54. PubMed ID: 14695224
[TBL] [Abstract][Full Text] [Related]
17. Mammary gland factor activated by prolactin on mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential.
Standke GJ; Meier VS; Groner B
Mol Endocrinol; 1994 Apr; 8(4):469-77. PubMed ID: 7519723
[TBL] [Abstract][Full Text] [Related]
18. Expression of milk protein genes is induced directly by exogenous STAT5 without prolactin-mediated signal transduction in transgenic mice.
Inuzuka H; Yamanouchi K; Tachi C; Tojo H
Mol Reprod Dev; 1999 Oct; 54(2):121-5. PubMed ID: 10471471
[TBL] [Abstract][Full Text] [Related]
19. EGF modulates expression of STAT5 in mammary epithelial cells.
Petersen H; Haldosén LA
Exp Cell Res; 1998 Sep; 243(2):347-58. PubMed ID: 9743594
[TBL] [Abstract][Full Text] [Related]
20. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
